Q32 Bio, Inc. (QTTB)
8.72
-0.10
(-1.13%)
USD |
NASDAQ |
Nov 13, 16:00
8.72
0.00 (0.00%)
After-Hours: 19:59
Q32 Bio Market Cap : 260.66M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 263.65M |
| November 11, 2026 | 275.01M |
| November 10, 2026 | 278.89M |
| November 09, 2026 | 279.19M |
| November 06, 2026 | 276.50M |
| November 05, 2026 | 264.55M |
| November 04, 2026 | 268.13M |
| November 03, 2026 | 261.85M |
| November 02, 2026 | 260.36M |
| October 30, 2026 | 211.49M |
| October 29, 2026 | 210.54M |
| October 28, 2026 | 215.05M |
| October 27, 2026 | 206.75M |
| October 26, 2026 | 200.57M |
| October 23, 2026 | 205.32M |
| October 22, 2026 | 208.88M |
| October 21, 2026 | 205.80M |
| October 20, 2026 | 204.61M |
| October 19, 2026 | 184.91M |
| October 16, 2026 | 178.50M |
| October 15, 2026 | 184.43M |
| October 14, 2026 | 190.13M |
| October 13, 2026 | 191.32M |
| October 12, 2026 | 207.46M |
| October 09, 2026 | 197.96M |
| Date | Value |
|---|---|
| October 08, 2026 | 192.03M |
| October 07, 2026 | 189.66M |
| October 06, 2026 | 192.50M |
| October 05, 2026 | 198.68M |
| October 02, 2026 | 195.35M |
| October 01, 2026 | 195.83M |
| September 30, 2026 | 196.30M |
| September 29, 2026 | 226.21M |
| September 28, 2026 | 219.09M |
| September 25, 2026 | 208.17M |
| September 24, 2026 | 218.85M |
| September 23, 2026 | 226.92M |
| September 22, 2026 | 250.90M |
| September 21, 2026 | 248.52M |
| September 18, 2026 | 250.18M |
| September 17, 2026 | 257.78M |
| September 16, 2026 | 260.63M |
| September 15, 2026 | 265.14M |
| September 14, 2026 | 258.97M |
| September 11, 2026 | 263.48M |
| September 10, 2026 | 254.46M |
| September 09, 2026 | 264.43M |
| September 08, 2026 | 277.48M |
| September 04, 2026 | 284.60M |
| September 03, 2026 | 303.83M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.361B |
| Beam Therapeutics, Inc. | 2.364B |
| Prime Medicine, Inc. | 769.04M |
| Korsana Biosciences, Inc. | 1.438B |
| Prelude Therapeutics, Inc. | 275.16M |
Market Cap Related Metrics
| PE Ratio | 2.609 |
| PS Ratio | 3.288 |
| Price to Book Value | 0.9061 |
| Price | 8.72 |
| Earnings Yield | 38.33% |
| Operating PE Ratio | 9.614 |
| Normalized PE Ratio | 2.605 |